Статті в журналах: "Outcomes validation"

1

Correro-Bermejo, Alba, Martina Fernández-Gutiérrez, Miriam Poza-Méndez, and Pilar Bas-Sarmiento. "Content and Clinical Validation of the Nursing Outcome “Health Literacy Behaviour”: A Validation Protocol." Healthcare 11, no. 4 (February 7, 2023): 481. http://dx.doi.org/10.3390/healthcare11040481.

Повний текст джерела

Анотація:

Health literacy (HL) is a result of health promotion and education that has been included as a nursing intervention since 2013. It was proposed, as a nursing activity, to “determine health literacy status at initiation of contact with the patient through informal and/or formal assessments”. Because of that, the outcome ‘Health Literacy Behaviour’ has been incorporated in the sixth edition of the Nursing Outcomes Classification (NOC). It collects the patient’s different HL levels and allows them to be identified and evaluated in a social and health context. Nursing outcomes are helpful and provide relevant information for the evaluation of nursing interventions. Objectives: To validate the contents of the nursing outcome ‘Health Literacy Behaviour (2015)’ in order to use them in nursing care plans, and to evaluate their psychometric properties, application level, and effectiveness in nursing care to detect low health literacy patients. Methods: a methodological two-phased study: (1) an exploratory study and content validation by expert consensus, who will evaluate revised content of nursing outcomes; (2) methodological design by clinical validation. Conclusion: The validation of this nursing outcome in NOC will enable the generation of a helpful tool that would facilitate nurses to set individualised and efficient care interventions and identify low health literacy populations.

Стилі APA, Harvard, Vancouver, ISO та ін.

2

Hollenberg, Jan, Kathryn M. Rost, Joylyn Humphrey, Richard R. Owen, and G. Richard Smith. "Validation of the Panic Outcomes Module." Evaluation & the Health Professions 20, no. 1 (March 1997): 81–95. http://dx.doi.org/10.1177/016327879702000106.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

3

Douglas, Alison, Lori Letts, Kevin Eva, and Julie Richardson. "Measurement of Harm Outcomes in Older Adults after Hospital Discharge: Reliability and Validity." Journal of Aging Research 2012 (2012): 1–7. http://dx.doi.org/10.1155/2012/150473.

Повний текст джерела

Анотація:

Objectives. Defining and validating a measure of safety contributes to further validation of clinical measures. The objective was to define and examine the psychometric properties of the outcome “incidents of harm.”Methods. The Incident of Harm Caregiver Questionnaire was administered to caregivers of older adults discharged from hospital by telephone. Caregivers completed daily logs for one month and medical charts were examined.Results. Test-retest reliability (n=38) was high for the occurrence of an incident of harm (yes/no; kappa = 1.0) and the type of incident (agreement = 100%). Validation against daily logs found no disagreement regarding occurrence or types of incidents. Validation with medical charts found no disagreement regarding incident occurrence and disagreement in half regarding incident type.Discussion. The data support the Incident of Harm Caregiver Questionnaire as a reliable and valid estimation of incidents for this sample and are important to researchers as a method to measure safety when validating clinical measures.

Стилі APA, Harvard, Vancouver, ISO та ін.

4

Palermo, Tonya Mizell. "Assessment of Chronic Pain in Children: Current Status and Emerging Topics." Pain Research and Management 14, no. 1 (2009): 21–26. http://dx.doi.org/10.1155/2009/236426.

Повний текст джерела

Анотація:

The present paper reviews the current status of research on assessment of chronic pain in children and adolescents, primarily in the context of treatment outcome research. Two specific primary aims are addressed. First, the degree of attention devoted to several major domains of chronic pain assessment (pain, physical functioning, role functioning, sleep and emotional functioning) is summarized, highlighting areas where further instrument development and validation are needed. Second, sensitivity of instruments within these domains is presented using data from clinical trials of psychological therapies aimed at treatment of chronic pain in children and adolescents. Findings demonstrate that although there has been recent progress in developing and validating a range of measures of pain-related outcomes, as of yet, very few clinical trials have included any outcomes other than pain intensity. Moreover, in randomized controlled trials where physical, role or emotional functioning outcomes have been included, there have been limited positive findings. The present paper lists some challenges and future directions in assessment of physical and role functioning, including highlighting emerging methodologies for assessment of physical activity and function in children with chronic pain. Clinical implications of integrating assessment tools into clinical practice are discussed. In conclusion, progress in developing and validating specific tools to assess important outcome domains in chronic pain has been realized. Opportunities exist for further measurement validation in most domains, and further theory-driven treatment research to match goals of the treatment with specific interventions and outcomes.

Стилі APA, Harvard, Vancouver, ISO та ін.

5

Anderson, Valerie C., Christina Carlson, and Deborah Shatin. "Outcomes of Spinal Cord Stimulation: Patient Validation." Neuromodulation: Technology at the Neural Interface 4, no. 1 (January 2001): 11–17. http://dx.doi.org/10.1046/j.1525-1403.2001.00011.x.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

6

Santilli, John, Robert Nathan, Jeffrey Glassheim, William Rockwell, and Karen Gold. "Validation of the rhinitis outcomes questionnaire (ROQ)." Annals of Allergy, Asthma & Immunology 86, no. 2 (February 2001): 222–25. http://dx.doi.org/10.1016/s1081-1206(10)62695-6.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

7

Matthews, Lynda R. "Development and Validation of the Work Outcomes Coding Scale." Australian Journal of Rehabilitation Counselling 8, no. 2 (January 2002): 90–98. http://dx.doi.org/10.1017/s1323892200000569.

Повний текст джерела

Анотація:

This article describes the development and validation of a new measure of post-accident work outcome and adjustment, the Work Outcomes Coding Scale (WOCS), whose items were derived from rehabilitation indices used individually by the Workcover Authority of New South Wales. Psychometric qualities of the 4-item scale were determined using two samples of hospitalised accident survivors who returned to work following their accident. The WOCS showed excellent internal consistency, correlated moderately to highly with other measures of role functioning and had low, significant correlations with factors connected with work adjustment. Low range WOCS scores were shown to be indicative of poor work outcomes and increasing need for vocational rehabilitation interventions.

Стилі APA, Harvard, Vancouver, ISO та ін.

8

SILVA, L. K. "Validation of Outcomes Through the Analysis of the Process-Outcome Relation: Limitations." International Journal for Quality in Health Care 9, no. 2 (January 1, 1997): 101–13. http://dx.doi.org/10.1093/intqhc/9.2.101.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

9

White, Peter, George Lewith, and Phil Prescott. "The Core Outcomes for Neck Pain: Validation of a New Outcome Measure." Spine 29, no. 17 (September 2004): 1923–30. http://dx.doi.org/10.1097/01.brs.0000137066.50291.da.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

10

Ackerman, Benjamin, Juned Siddique, and Elizabeth A. Stuart. "Calibrating validation samples when accounting for measurement error in intervention studies." Statistical Methods in Medical Research 30, no. 5 (February 23, 2021): 1235–48. http://dx.doi.org/10.1177/0962280220988574.

Повний текст джерела

Анотація:

Many lifestyle intervention trials depend on collecting self-reported outcomes, such as dietary intake, to assess the intervention’s effectiveness. Self-reported outcomes are subject to measurement error, which impacts treatment effect estimation. External validation studies measure both self-reported outcomes and accompanying biomarkers, and can be used to account for measurement error. However, in order to account for measurement error using an external validation sample, an assumption must be made that the inferences are transportable from the validation sample to the intervention trial of interest. This assumption does not always hold. In this paper, we propose an approach that adjusts the validation sample to better resemble the trial sample, and we also formally investigate when bias due to poor transportability may arise. Lastly, we examine the performance of the methods using simulation, and illustrate them using PREMIER, a lifestyle intervention trial measuring self-reported sodium intake as an outcome, and OPEN, a validation study measuring both self-reported diet and urinary biomarkers.

Стилі APA, Harvard, Vancouver, ISO та ін.

11

Wan, Li, and Ying Jin. "Assessment of model validation outcomes of a new recursive spatial equilibrium model for the Greater Beijing." Environment and Planning B: Urban Analytics and City Science 46, no. 5 (September 27, 2017): 805–25. http://dx.doi.org/10.1177/2399808317732575.

Повний текст джерела

Анотація:

Robust calibration and validation of applied urban models are prerequisites for their successful, policy-cogent use. This is particularly important today when expert assessment is questioned and closely scrutinized. This paper proposes a new model calibration-validation strategy based on a spatial equilibrium model that incorporates multiple time horizons, such that the predictive capabilities of the model can be empirically tested. The model is implemented for the Greater Beijing city region and the model validation strategy is demonstrated over the Census years 2000 to 2010. Through forward/backward forecasting, the model validation helps to verify the stability of the model parameters as well as the predictive capabilities of the recursive equilibrium framework. The proposed modelling strategy sets a new standard for verifying and validating recursive equilibrium models. We also consider the wider implications of the approach.

Стилі APA, Harvard, Vancouver, ISO та ін.

12

Krumm, Stefan, Joachim Hüffmeier, and Filip Lievens. "Experimental Test Validation." European Journal of Psychological Assessment 35, no. 2 (March 2019): 225–32. http://dx.doi.org/10.1027/1015-5759/a000393.

Повний текст джерела

Анотація:

Abstract. Although the vast majority of validation studies rely on correlational validity evidence, there is an increased recognition that validity should also focus on whether variations in the focal psychological attribute lead to variations in the measurement outcomes. Therefore, calls have been made that validity evidence should also be gathered through experiments. Existing experimental validation strategies focus on manipulating psychological attributes and their effects on measurement outcomes. In the current manuscript, we present an additional and complementary approach that focuses on manipulating test elements (instead of psychological attributes) that are considered indispensable for test functioning. Examples from personality, situational judgment, emotional intelligence, and reading comprehension domains are presented to illustrate our approach. The presented approach is integrated into existing validation strategies.

Стилі APA, Harvard, Vancouver, ISO та ін.

13

Yarbrough, Chester K., Jacob K. Greenberg, Matthew D. Smyth, Jeffrey R. Leonard, Tae Sung Park, and David D. Limbrick. "External validation of the Chicago Chiari Outcome Scale." Journal of Neurosurgery: Pediatrics 13, no. 6 (June 2014): 679–84. http://dx.doi.org/10.3171/2014.3.peds13503.

Повний текст джерела

Анотація:

Object Historically, assessment of clinical outcomes following surgical management of Chiari malformation Type I (CM-I) has been challenging due to the lack of a validated instrument for widespread use. The Chicago Chiari Outcome Scale (CCOS) is a novel system intended to provide a less subjective evaluation of outcomes for patients with CM-I. The goal of this study was to externally validate the performance of the CCOS. Methods Patients undergoing surgery for CM-I between 2001 and 2012 were reviewed (n = 292). Inclusion criteria for this study were as follows: 1) patients receiving primary posterior fossa decompression; 2) at least 5.5 months of postoperative clinical follow-up; and 3) patients ≤ 18 years of age at the time of surgery. Outcomes were evaluated using the CCOS, along with a “gestalt” impression of whether patients experienced significant improvement after surgery. A subgroup of 118 consecutive patients undergoing operations between 2008 and 2010 was selected for analysis of interrater reliability (n = 73 meeting inclusion/exclusion criteria). In this subgroup, gestalt and CCOS scores were independently determined by 2 reviewers, and interrater reliability was assessed using the intraclass correlation coefficient (ICC) and kappa (κ) statistic. Results The median CCOS score was 14, and 67% of patients had improved gestalt scores after surgery. Overall, the CCOS was effective at identifying patients with improved outcome after surgery (area under curve = 0.951). The interrater reliability of the CCOS (ICC = 0.71) was high, although the reliability of the component scores ranged from poor to good (ICC 0.23–0.89). The functionality subscore demonstrated a low ICC and did not add to the predictive ability of the logistic regression model (likelihood ratio = 1.8, p = 0.18). When analyzing gestalt outcome, there was moderate agreement between raters (κ = 0.56). Conclusions In this external validation study, the CCOS was effective at identifying patients with improved outcomes and proved more reliable than the authors' gestalt impression of outcome. However, certain component subscores (functionality and nonpain symptoms) were found to be less reliable, and may benefit from further definition in score assignment. In particular, the functionality subscore does not add to the predictive ability of the CCOS, and may be unnecessary. Overall, the authors found the CCOS to be an improvement over the previously used assessment of outcome at their institution.

Стилі APA, Harvard, Vancouver, ISO та ін.

14

Humphreys, Christopher, Sarah Fletcher, Nishan Sharma, Rahim Kachra, and Shannon Marie Ruzycki. "Validation of Electronic Health Record Detection of Patient Safety Outcomes." Canadian Journal of General Internal Medicine 14, no. 3 (August 21, 2019): 16–22. http://dx.doi.org/10.22374/cjgim.v14i3.321.

Повний текст джерела

Анотація:

Background: Adverse events (AE) are common for hospitalized Canadians, and lead to worse patient outcomes. Monitoring patient safety is logistically challenging. We aimed to validate the use of our electronic health record (EHR) to monitor important patient safety. Methods: EHR data was used to identify patients who were exposed to one of four high-priority safety outcomes: venous thromboembolism, dysglycemia, Clostridium difficile(C. difficile) infection, and prolonged nil per os(NPO) orders. A manual chart review was performed to determine the sensitivity and specificity of the EHR for each patient safety outcome. Results: The sensitivity and specificity ranged from 38.4% to 78.1% and 88.1 to 99.2%, respectively, for the prespecified patient safety outcomes. Conclusion: The EHR is reasonably sensitive and specific to monitor rates of dysglycemia, C. difficileinfection, and prolonged NPO in medical inpatients, but does not have adequate sensitivity to be used to capture venous thromboembolism safety outcomes.

Стилі APA, Harvard, Vancouver, ISO та ін.

15

Wibawa, Setya Chendra. "THE DESIGN AND IMPLEMENTATION OF AN EDUCATIONAL MULTIMEDIA INTERACTIVE OPERATION SYSTEM USING LECTORA INSPIRE." Elinvo (Electronics, Informatics, and Vocational Education) 2, no. 1 (May 15, 2017): 74–79. http://dx.doi.org/10.21831/elinvo.v2i1.16633.

Повний текст джерела

Анотація:

The objective this research to produce a valid interactive learning tool and practice based on learning media Lectora Inspire; knowing the student response against the learning tool, and knowing the student learning outcomes after using Lectora inspire learning media. Research and development of the research method using ADDIE model. Research with the learning media to be tested against the 32 student X level of Vocational High School and the subject is operation system. Research analysis results obtained through student response and question form reserved post-test. Validation of results obtained through validation by the validator which consists of one lecturer of Informatics and two teachers in a primary against 83.3% of Planning of Learning validation, validation against reserved posttest of 93.9% and validation against the media learner Lectora inspire of 100%, the results of all the validations that meets the criteria for applied research. The percentage of the average student response against Lectora media inspire 85.9%. While the percentage of student learning results expressed satisfaction with the presentation of graduation of 84.375% means it can be inferred that the media Lectora inspire gets good results and media can be said to be effective as a learning tool to supporting study students.

Стилі APA, Harvard, Vancouver, ISO та ін.

16

Lafage, Virginie, Neil J. Bharucha, Frank Schwab, Robert A. Hart, Douglas Burton, Oheneba Boachie-Adjei, Justin S. Smith, et al. "Multicenter validation of a formula predicting postoperative spinopelvic alignment." Journal of Neurosurgery: Spine 16, no. 1 (January 2012): 15–21. http://dx.doi.org/10.3171/2011.8.spine11272.

Повний текст джерела

Анотація:

Object Sagittal spinopelvic imbalance is a major contributor to pain and disability for patients with adult spinal deformity (ASD). Preoperative planning is essential for pedicle subtraction osteotomy (PSO) candidates; however, current methods are often inaccurate because no formula to date predicts both postoperative sagittal balance and pelvic alignment. The authors of this study aimed to evaluate the accuracy of 2 novel formulas in predicting postoperative spinopelvic alignment after PSO. Methods This study is a multicenter retrospective consecutive PSO case series. Adults with spinal deformity (> 21 years old) who were treated with a single-level lumbar PSO for sagittal imbalance were evaluated. All patients underwent preoperative and a minimum of 6-month postoperative radiography. Two novel formulas were used to predict the postoperative spinopelvic alignment. The results predicted by the formulas were then compared with the actual postoperative radiographic values, and the formulas' ability to identify successful (sagittal vertical axis [SVA] ≤ 50 mm and pelvic tilt [PT] ≤ 25°) and unsuccessful (SVA > 50 mm or PT > 25°) outcomes was evaluated. Results Ninety-nine patients met inclusion criteria. The median absolute error between the predicted and actual PT was 4.1° (interquartile range 2.0°–6.4°). The median absolute error between the predicted and actual SVA was 27 mm (interquartile range 11–47 mm). Forty-one of 54 patients with a formula that predicted a successful outcome had a successful outcome as shown by radiography (positive predictive value = 0.76). Forty-four of 45 patients with a formula that predicted an unsuccessful outcome had an unsuccessful outcome as shown by radiography (negative predictive value = 0.98). Conclusions The spinopelvic alignment formulas were accurate when predicting unsuccessful outcomes but less reliable when predicting successful outcomes. The preoperative surgical plan should be altered if an unsuccessful result is predicted. However, even after obtaining a predicted successful outcome, surgeons should ensure that the predicted values are not too close to unsuccessful values and should identify other variables that may affect alignment. In the near future, it is anticipated that the use of these formulas will lead to better surgical planning and improved outcomes for patients with complex ASD.

Стилі APA, Harvard, Vancouver, ISO та ін.

17

Lamping, Donna L., Pamela Rowe, Aileen Clarke, Nick Black, and Leila Lessof. "Development and validation of the menorrhagia outcomes questionnaire." BJOG: An International Journal of Obstetrics and Gynaecology 105, no. 7 (July 1998): 766–79. http://dx.doi.org/10.1111/j.1471-0528.1998.tb10209.x.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

18

Dias Emidio, Suellen Cristina, Sue Moorhead, Henrique Ceretta Oliveira, T. Heather Herdman, Ana Railka de Souza Oliveira‐Kumakura, and Elenice Valentin Carmona. "Validation of Nursing Outcomes Related to Breastfeeding Establishment." International Journal of Nursing Knowledge 31, no. 2 (April 2020): 134–44. http://dx.doi.org/10.1111/2047-3095.12256.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

19

Vickers, Andrew J. "Validation of Patient-Reported Outcomes: A Low Bar." Journal of Clinical Oncology 37, no. 23 (August 10, 2019): 1990–92. http://dx.doi.org/10.1200/jco.19.01126.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

20

Choi, S. "PCN91 VALIDATION OF HEALTH OUTCOMES RESEARCH OF CANCER." Value in Health 13, no. 3 (May 2010): A40—A41. http://dx.doi.org/10.1016/s1098-3015(10)72180-x.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

21

Scherb, Cindy A., Carla Gene Rapp, Marion Johnson, and Meridean Maas. "The Nursing Outcomes Classification: Validation by Rehabilitation Nurses." Rehabilitation Nursing 23, no. 4 (July 8, 1998): 174–91. http://dx.doi.org/10.1002/j.2048-7940.1998.tb01776.x.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

22

HEALD, ALISON E., EDWARD J. FUDMAN, PERVIN ANKLESARIA, and PHILIP J. MEASE. "Single-joint Outcome Measures: Preliminary Validation of Patient-reported Outcomes and Physical Examination." Journal of Rheumatology 37, no. 5 (March 15, 2010): 1042–48. http://dx.doi.org/10.3899/jrheum.090827.

Повний текст джерела

Анотація:

Objective.To assess the validity, responsiveness, and reliability of single-joint outcome measures for determining target joint (TJ) response in patients with inflammatory arthritis.Methods.Patient-reported outcomes (PRO), consisting of responses to single questions about TJ global status on a 100-mm visual analog scale (VAS; TJ global score), function on a 100-mm VAS (TJ function score), and pain on a 5-point Likert scale (TJ pain score) were piloted in 66 inflammatory arthritis subjects in a phase 1/2 clinical study of an intraarticular gene transfer agent and compared to physical examination measures (TJ swelling, TJ tenderness) and validated function questionnaires (Disabilities of the Arm, Shoulder and Hand scale, Rheumatoid Arthritis Outcome Score, and the Health Assessment Questionnaire). Construct validity was assessed by evaluating the correlation between the single-joint outcome measures and validated function questionnaires using Spearman’s rank correlation. Responsiveness or sensitivity to change was assessed through calculating effect size and standardized response means (SRM). Reliability of physical examination measures was assessed by determining interobserver agreement.Results.The single-joint PRO were highly correlated with each other and correlated well with validated functional measures. The TJ global score exhibited modest effect size and modest SRM that correlated well with the patient’s assessment of response on a 100-mm VAS. Physical examination measures exhibited high interrater reliability, but correlated less well with validated functional measures and the patient’s assessment of response.Conclusion.Single-joint PRO, particularly the TJ global score, are simple to administer and demonstrate construct validity and responsiveness in patients with inflammatory arthritis. (ClinicalTrials.gov identifier NCT00126724)

Стилі APA, Harvard, Vancouver, ISO та ін.

23

Thomas‐Stonell, Nancy, Bruce Oddson, Bernadette Robertson, and Peter Rosenbaum. "Validation of the Focus on the Outcomes of Communication under Six outcome measure." Developmental Medicine & Child Neurology 55, no. 6 (March 6, 2013): 546–52. http://dx.doi.org/10.1111/dmcn.12123.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

24

Gehringer, C., G. Martin, K. Hyrich, S. Verstappen, and J. Sergeant. "AB1435 CLINICAL PREDICTION MODELS FOR METHOTREXATE OUTCOMES IN PATIENTS WITH RHEUMATOID ARTHRITIS: SYSTEMATIC REVIEW AND CRITICAL APPRAISAL." Annals of the Rheumatic Diseases 81, Suppl 1 (May 23, 2022): 1823.2–1824. http://dx.doi.org/10.1136/annrheumdis-2022-eular.2079.

Повний текст джерела

Анотація:

BackgroundMethotrexate (MTX) is the preferred first line therapy for rheumatoid arthritis (RA). MTX has several advantages over other treatments including effectiveness and low cost; however, around 40% of patients are classed as non-responders after 6 months (1). Therefore, there is a clinical need to identify patients at high-risk of poor outcomes, such that patients could potentially be fast tracked onto alternative therapies to improve their clinical outcomes and quality of life. Such risk stratification is possible through prognostic prediction models, although models which have previously been developed appear to have had little impact on practice. This may be in part due to methodological features of their development and validation but, to date, no review has collated the evidence in this field.ObjectivesThis systematic review aimed to (i) identify and summarise multivariable prediction models of MTX treatment outcomes in biologic-naïve adult RA patients, and (ii) critically appraise their methodological properties.MethodsThe electronic databases Medline and Embase were searched to identify studies developing or validating prediction models of MTX outcomes in the population of interest, including demographic, disease-specific or treatment-related covariates, published after 2005. Models were stratified by outcome definition, and information on participants, predictors, model performance, handling of missing data and model validation were extracted. A risk of bias (ROB) assessment using PROBAST (prediction model risk of bias assessment tool) was carried out. Two reviewers were independently involved in screening, data extraction, and ROB stages.ResultsThe included studies used three main outcome definitions: a state of disease activity, such as low disease activity or remission; the EULAR response criteria; or discontinuation due to adverse events (AEs). Some studies incorporated AEs into a composite outcome with disease activity and few accounted for potential competing risks, which are events that preclude the occurrence of the primary outcome of interest. Not handling competing risks may result in under-prediction, leading to potentially compromised risk stratification. There was a lack of internal validation using cross sampling techniques, which is critical for reducing overfitting, as well as external validation in new data, a process necessary to ensure reproducibility and generalisability of a prediction model to the larger patient population. Missing data was mostly handled using complete case analysis, leading to potentially biased risk estimates. The ROB assessment showed overall high ROB of the included studies.ConclusionThis systematic review summarises current prediction models of MTX treatment outcomes in RA. It highlights several methodological shortcomings, such as poor handling of missing data and competing risks to the primary outcome, and a lack of internal and external validation. These should be addressed in future model development and validation to improve accuracy of predictions. Without tackling these issues, prediction of MTX treatment outcomes will remain at high risk of bias and should not be recommended for informing risk stratification for RA treatment decisions.References[1]Sergeant JC, Hyrich KL, Anderson J, Kopec-Harding K, Hope HF, Symmons DPM, et al. Prediction of primary non-response to methotrexate therapy using demographic, clinical and psychosocial variables: Results from the UK Rheumatoid Arthritis Medication Study (RAMS). Arthritis Res Ther. 2018;20(1):1–11.Disclosure of InterestsCelina Gehringer: None declared, Glen Martin: None declared, Kimme Hyrich Speakers bureau: Abbvie, Grant/research support from: BMS and Pfizer, Suzanne Verstappen: None declared, Jamie Sergeant: None declared

Стилі APA, Harvard, Vancouver, ISO та ін.

25

Efendi, Nyena, Gunawan Gunawan, and Ahmad Busyairi. "Pengembangan Perangkat Pembelajaran Model Generatif Untuk Meningkatkan Hasil Belajar Fisika Peserta Didik." Jurnal Pendidikan Fisika dan Teknologi 8, SpecialIssue (June 30, 2022): 76–84. http://dx.doi.org/10.29303/jpft.v8ispecialissue.3762.

Повний текст джерела

Анотація:

The purfose of this study is to determine the feasibility of the learning tools based generative. This type of research is research and development that refers to a 4-D model which consists of four stages of development, namely define, design, develop and disseminate. The learning tools developed in this research are syllabus, RPP, teaching materials, LKPD, and cognitive learning outcomes test instruments. This research is limited to the content and construct validation stage of learning devices. Validation is carried out by the validator using a validation test instrument in the from of a questionnaire. The results of the validation of learning tools in the form of syllabus, RPP, teaching materials, LKPD, and cognitive learning outcomes test instruments werw obtained in the valid category. Based on the results and discussion of this research, it can be concluded that the learning tools developed are suitable for us in high school physics learning activities.

Стилі APA, Harvard, Vancouver, ISO та ін.

26

Silva, Natália Chantal Magalhães da, Ana Railka de Souza Oliveira, and Emília Campos de Carvalho. "Knowledge produced from the outcomes of the "Nursing Outcomes Classification - NOC": integrative review." Revista Gaúcha de Enfermagem 36, no. 4 (December 2015): 104–11. http://dx.doi.org/10.1590/1983-1447.2015.04.53339.

Повний текст джерела

Анотація:

Objective: To identify the knowledge produced from the outcomes of the Nursing Outcomes Classification (NOC). Method: A literature review using the integrative databases: Latin American and Caribbean Health Sciences (LILACS), US National Library of Medicine (PubMed), Cumulative Index to Nursing & Allied Health Literature (CINAHL) and Scopus Info Site (SCOPUS), during the months of August and September 2014. Results: The review consisted of 21 articles that addressed different issues: Translation and Cultural adaptation (4.77%); Applicability in clinical practice (33.33%); and, Validation (63.90%). Analysis of these articles showed that the knowledge produced from the Nursing Outcomes Classification includes translation and cultural adaptation, evaluation of applicability and validation of its items. Conclusion: Considering the continuous evolution of this classification, periodic reviews should be carried out to identify the knowledge, use and effects of the NOC.

Стилі APA, Harvard, Vancouver, ISO та ін.

27

Hulkkonen, S., J. P. Repo, A. Häkkinen, J. Karppinen, and J. Ryhänen. "Cross-Cultural Adaptation and Validation of the Finnish Version of the Michigan Hand Outcomes Questionnaire." Scandinavian Journal of Surgery 109, no. 2 (December 13, 2018): 159–65. http://dx.doi.org/10.1177/1457496918818981.

Повний текст джерела

Анотація:

Background and Aims: Michigan Hand Outcomes Questionnaire is a widely used patient-reported outcome measure in hand surgery. The aim of this study was to translate and validate the Michigan Hand Outcomes Questionnaire into Finnish for Finnish patients with hand problems following international standards and guidelines. Material and Methods: The original English Michigan Hand Outcomes Questionnaire was translated into Finnish. Altogether, 115 patients completed the Finnish Michigan Hand Outcomes Questionnaire, and reference outcomes: Disabilities of the Arm and Shoulder, EQ-5D 3L and pain intensity on a visual analog scale. Grip and key pinch forces were measured. After 1–2 weeks, 63 patients completed the Finnish Michigan Hand Outcomes Questionnaire the second time. The Michigan Hand Outcomes Questionnaire was analyzed for internal consistency, repeatability, correlations with the reference outcomes, and factor analysis. Results: Cronbach’s alpha ranged from 0.90 to 0.97 in all the Michigan Hand Outcomes Questionnaire subscales, showing high internal consistency. The intraclass correlation coefficient showed good to excellent test–retest reliability ranging from 0.66 to 0.91 in all the Michigan Hand Outcomes Questionnaire subscales. In factor analysis, the structure with six subscales was not confirmed. All the subscales correlated with Disabilities of the Arm and Shoulder score, and five subscales correlated with EQ-5D index. Conclusion: The Finnish version of the Michigan Hand Outcomes Questionnaire showed similar properties compared to the original English version and thus can be used as patient-reported outcome measure for Finnish patients with hand problems.

Стилі APA, Harvard, Vancouver, ISO та ін.

28

Lopes, Camila Takáo, Camila de Souza Carneiro, Vinicius Batista Santos, and Alba Lúcia Bottura Leite de Barros. "Nursing diagnoses validated in cardiology in Brazil: integrative literature review." Acta Paulista de Enfermagem 25, spe1 (2012): 155–60. http://dx.doi.org/10.1590/s0103-21002012000800024.

Повний текст джерела

Анотація:

OBJECTIVE: To identify nursing diagnoses (ND) currently appearing in the NANDA-I taxonomy, validated in the area of cardiology in Brazil. METHODS: An integrative literature review, guided by the following question: what nursing diagnoses were validated in Brazil? Eleven works were analyzed: three content validations and eight clinical validations. RESULTS: The NDs validated were: activity intolerance, decreased cardiac output, spiritual distress, deficient knowledge, excessive fluid volume, ineffective airway clearance, ineffective peripheral tissue perfusion, fear, anxiety, and pain. The highlights were the production of the graduate programs in public institutions, the validation of defining characteristics, models of validation and the modified Fehring criteria for selection of experts . The clinical validation model was used for NDs of the psychobiological sphere; the content validation model was used mainly for NDs in the psychosocial and psychospiritual spheres. CONCLUSION: The knowledge produced can provide a basis for future studies on the relevance of the content of nursing outcomes in the evaluation of the effectiveness of nursing interventions in the country.

Стилі APA, Harvard, Vancouver, ISO та ін.

29

Newman, William C., Paul S. Kubilis, and Brian L. Hoh. "Validation of a neurovascular comorbidities index for retrospective database analysis." Journal of Neurosurgery 130, no. 1 (January 2018): 273–77. http://dx.doi.org/10.3171/2017.8.jns171413.

Повний текст джерела

Анотація:

OBJECTIVEComorbidities have a significant effect on patient outcomes. Accounting for this effect is especially important in retrospective reviews of large databases; overpowered studies are at risk for finding significant results because of inaccurate patient risk stratification. The authors previously created a neurovascular comorbidities index (NCI) for patients with an unruptured intracranial aneurysm and found that the model’s ability to predict patient outcomes was statistically significantly improved over that of the routinely used Charlson Comorbidity Index (CCI) and Elixhauser Comorbidity Index (ECI). In this study, the authors aimed to validate use of the NCI over that of the CCI and ECI for risk stratification of patients with other neurovascular diseases.METHODSThe authors queried the National (Nationwide) Inpatient Sample database for the years 2002–2012 to compare the accuracy of the previously validated NCI with that of the CCI and ECI with respect to predicting outcomes for patients who had an arteriovenous malformation, a ruptured intracranial aneurysm, carotid artery stenosis, or dural arteriovenous fistula and who underwent surgical intervention.RESULTSFor patients with an arteriovenous malformation, the NCI outperformed the CCI and ECI in predicting poor outcome, hospital length of stay (LOS), and total cost but was equivalent to the CCI in predicting death. For patients with a ruptured intracranial aneurysm, the NCI outperformed the ECI and CCI in predicting death, poor outcome, LOS, and total cost. For patients with carotid artery stenosis, the NCI outperformed the ECI and CCI in predicting LOS, but it was equivalent to the ECI in predicting death and total cost and inferior to the CCI in predicting poor outcome (p < 0.002 for all). An insufficient number of patients with dural arteriovenous fistula who underwent surgical intervention were available for analysis (n < 10), and they therefore were excluded from study. For 11 of 12 metrics, the NCI was the significantly more efficient model.CONCLUSIONSThe NCI outperforms the CCI and ECI by providing more appropriate and efficient risk stratification of patients regarding death, outcome, LOS, and cost. Given this finding, the NCI should be used for retrospective reviews of patient outcomes instead of the CCI or ECI.

Стилі APA, Harvard, Vancouver, ISO та ін.

30

Roos, Ewa M., Sveinbjörn Brandsson, and Jon Karlsson. "Validation of the Foot and Ankle Outcome Score for Ankle Ligament Reconstruction." Foot & Ankle International 22, no. 10 (October 2001): 788–94. http://dx.doi.org/10.1177/107110070102201004.

Повний текст джерела

Анотація:

We studied the validity and reliability of the Foot and Ankle Outcome Score (FAOS) when used to evaluate the outcome of 213 patients (mean age 40 years, 85 females) who underwent anatomical reconstruction of the lateral ankle ligaments with an average postoperative follow-up of 12 years (range, three to 24 years). The FAOS is a 42-item questionnaire assessing patient-relevant outcomes in five separate subscales (Pain, Other Symptoms, Activities of Daily Living, Sport and Recreation Function, Foot- and Ankle-Related Quality of Life). The FAOS met set criteria of validity and reliability. The FAOS appears to be useful for the evaluation of patient-relevant outcomes related to ankle reconstruction.

Стилі APA, Harvard, Vancouver, ISO та ін.

31

Joundi, Raed A., Gustavo Saposnik, Rosemary Martino, Jiming Fang, and Moira K. Kapral. "Development and Validation of a Prognostic Tool for Direct Enteral Tube Insertion After Acute Stroke." Stroke 51, no. 6 (June 2020): 1720–26. http://dx.doi.org/10.1161/strokeaha.120.028949.

Повний текст джерела

Анотація:

Background and Purpose— We aimed to create a novel prognostic risk score to estimate outcomes after direct enteral tube placement in acute stroke. Methods— We used the Ontario Stroke Registry and linked databases to obtain clinical information on all patients with direct enteral tube insertion after ischemic stroke or intracerebral hemorrhage from July 1, 2003 to June 30, 2010 (derivation cohort) and July 1, 2010 to March 31, 2013 (validation cohort). We used multivariable regression to assign scores to predictor variables for 3 outcomes after tube placement: favorable outcome (discharge modified Rankin Scale score 0–3 and alive at 90 days), poor outcome (discharge modified Rankin Scale score 5 or death at 90 days), and 30-day mortality. Results— Variables associated with a favorable outcome were younger age, preadmission independence, ischemic stroke rather than intracerebral hemorrhage, lower stroke severity, and a shorter time between stroke and tube placement. Variables associated with a poor outcome were older age, preadmission dependence, atrial fibrillation, greater stroke severity, and tracheostomy. Age, preadmission dependence, atrial fibrillation, cancer, chronic obstructive pulmonary disease, and shorter time to tube placement were associated with increased 30-day mortality. Using these variables, we created an online calculator to facilitate estimation of individual patient risk of favorable and poor outcomes. C -statistic in the validation cohort was 0.82 for favorable outcome, 0.65 for poor outcome, and 0.62 for 30-day mortality, and calibration was adequate. Conclusions— We developed risk scores to estimate outcomes after direct enteral tube insertion for acute dysphagic stroke. This information may be useful in discussions with patients and families when there is prognostic uncertainty surrounding outcomes with direct enteral tube placement after stroke.

Стилі APA, Harvard, Vancouver, ISO та ін.

32

Giurgiu, Marco, Simon Kolb, Carina Nigg, Alexander Burchartz, Irina Timm, Marlissa Becker, Ellen Rulf, et al. "Assessment of 24-hour physical behaviour in children and adolescents via wearables: a systematic review of free-living validation studies." BMJ Open Sport & Exercise Medicine 8, no. 2 (May 2022): e001267. http://dx.doi.org/10.1136/bmjsem-2021-001267.

Повний текст джерела

Анотація:

ObjectivesStudies that assess all three dimensions of the integrative 24-hour physical behaviour (PB) construct, namely, intensity, posture/activity type and biological state, are on the rise. However, reviews on validation studies that cover intensity, posture/activity type and biological state assessed via wearables are missing.DesignSystematic review. The risk of bias was evaluated by using the QUADAS-2 tool with nine signalling questions separated into four domains (ie, patient selection/study design, index measure, criterion measure, flow and time).Data sourcesPeer-reviewed validation studies from electronic databases as well as backward and forward citation searches (1970–July 2021).Eligibility criteria for selecting studiesWearable validation studies with children and adolescents (age <18 years). Required indicators: (1) study protocol must include real-life conditions; (2) validated device outcome must belong to one dimension of the 24-hour PB construct; (3) the study protocol must include a criterion measure; (4) study results must be published in peer-reviewed English language journals.ResultsOut of 13 285 unique search results, 76 articles with 51 different wearables were included and reviewed. Most studies (68.4%) validated an intensity measure outcome such as energy expenditure, but only 15.9% of studies validated biological state outcomes, while 15.8% of studies validated posture/activity type outcomes. We identified six wearables that had been used to validate outcomes from two different dimensions and only two wearables (ie, ActiGraph GT1M and ActiGraph GT3X+) that validated outcomes from all three dimensions. The percentage of studies meeting a given quality criterion ranged from 44.7% to 92.1%. Only 18 studies were classified as ‘low risk’ or ‘some concerns’.SummaryValidation studies on biological state and posture/activity outcomes are rare in children and adolescents. Most studies did not meet published quality principles. Standardised protocols embedded in a validation framework are needed.PROSPERO registration numberCRD42021230894.

Стилі APA, Harvard, Vancouver, ISO та ін.

33

Nordberg, Samuel S., Christian Moltu, and Marit Råbu. "Norwegian translation and validation of a routine outcomes monitoring measure: The treatment outcome package." Nordic Psychology 68, no. 2 (September 15, 2015): 124–43. http://dx.doi.org/10.1080/19012276.2015.1071204.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

34

Sallaberger, Sebastian, Lukas Buchwinkler, Susanne Eder, Stefan Schneeberger, Gert Mayer, and Markus Pirklbauer. "Population Characteristics and Clinical Outcomes from the Renal Transplant Outcome Prediction Validation Study (TOPVAS)." Journal of Clinical Medicine 11, no. 24 (December 14, 2022): 7421. http://dx.doi.org/10.3390/jcm11247421.

Повний текст джерела

Анотація:

Kidney transplantation is the preferred method for selected patients with kidney failure. Despite major improvements over the last decades, a significant proportion of organs are still lost every year. Causes of graft loss and impaired graft function are incompletely understood and prognostic tools are lacking. Here, we describe baseline characteristics and outcomes of the non-interventional Transplant Outcome Prediction Validation Study (TOPVAS). A total of 241 patients receiving a non-living kidney transplant were recruited in three Austrian transplantation centres and treated according to local practices. Clinical information as well as blood and urine samples were obtained at baseline and consecutive follow-ups up to 24 months. Out of the overall 16 graft losses, 11 occurred in the first year. The patient survival rate was 96.7% (95% CI: 94.3–99.1%) in the first year and 94.3% (95% CI: 91.1–97.7%) in the second year. Estimated glomerular filtration rate (eGFR) improved from 37.1 ± 14.0 mL/min/1.73 m2 at hospital discharge to 45.0 ± 14.5 mL/min/1.73 m2 at 24 months. The TOPVAS study provides information on current kidney graft and patient survival, eGFR trajectories, and rejection rates, as well as infectious and surgical complication rates under different immunosuppressive drug regimens. More importantly, it provides an extensive and well-characterized biobank for the future discovery and validation of prognostic methods.

Стилі APA, Harvard, Vancouver, ISO та ін.

35

Howard, Kristen P., Erin M. Altenburger, and Jennifer S. Cheavens. "Validation predicting premature drop-out from treatment provided in training clinics." Behavioural and Cognitive Psychotherapy 48, no. 1 (July 15, 2019): 116–20. http://dx.doi.org/10.1017/s1352465819000420.

Повний текст джерела

Анотація:

AbstractBackground:Therapist validation in treatment is theorized to be related to positive outcomes (Linehan, 1993), including keeping patients in therapy longer.Aims:We sought to evaluate the role of therapist validation from both therapists’ and clients’ perspectives as a predictor of drop-out from psychotherapy in three cognitive behavioural training clinics.Method:Clients in psychotherapy (n = 50; 80% female; 82% Caucasian) and their trainee therapists (n = 22; 68% female; 86% Caucasian) rated validation by the therapist at each of four early sessions of therapy.Results:After accounting for symptom severity, clients who reported greater therapist validation were less likely to drop out of treatment. Therapist ratings of their own validating behaviours were unrelated to client drop-out. Therapist experience moderated the relation between client-rated validation and drop-out, such that validation was unrelated to drop-out for more experienced therapists.Conclusions:Assessing and attending to client perceptions of validation by the therapist early in treatment, with brief self-report inventories, can alert therapists to clients at greater risk of drop-out.

Стилі APA, Harvard, Vancouver, ISO та ін.

36

Hellenkamp, Kristian, Piotr Pruszczyk, David Jiménez, Anna Wyzgał, Deisy Barrios, Michał Ciurzyński, Raquel Morillo, et al. "Prognostic impact of copeptin in pulmonary embolism: a multicentre validation study." European Respiratory Journal 51, no. 4 (March 29, 2018): 1702037. http://dx.doi.org/10.1183/13993003.02037-2017.

Повний текст джерела

Анотація:

To externally validate the prognostic impact of copeptin, either alone or integrated in risk stratification models, in pulmonary embolism (PE), we performed a post hoc analysis of 843 normotensive PE patients prospectively included in three European cohorts.Within the first 30 days, 21 patients (2.5%, 95% CI 1.5–3.8) had an adverse outcome and 12 (1.4%, 95% CI 0.7–2.5) died due to PE. Patients with copeptin ≥24 pmol·L−1 had a 6.3-fold increased risk for an adverse outcome (95% CI 2.6–15.5, p<0.001) and a 7.6-fold increased risk for PE-related death (95% CI 2.3–25.6, p=0.001). Risk classification according to the 2014 European Society of Cardiology (ESC) guideline algorithm identified 248 intermediate-high-risk patients (29.4%) with 5.6% (95% CI 3.1–9.3) at risk of adverse outcomes. A stepwise biomarker-based risk assessment strategy (based on high-sensitivity troponin T, N-terminal pro-brain natriuretic peptide and copeptin) identified 123 intermediate-high-risk patients (14.6%) with 8.9% (95% CI 4.5–15.4) at risk of adverse outcomes. The identification of patients at higher risk was even better when copeptin was measured on top of the 2014 ESC algorithm in intermediate-high-risk patients (adverse outcome OR 11.1, 95% CI 4.6–27.1, p<0.001; and PE-related death OR 13.5, 95% CI 4.2–43.6, p<0.001; highest risk group versus all other risk groups). This identified 85 patients (10.1%) with 12.9% (95% CI 6.6–22.0) at risk of adverse outcomes and 8.2% (95% CI 3.4–16.2) at risk of PE-related deaths.Copeptin improves risk stratification of normotensive PE patients, especially when identifying patients with an increased risk of an adverse outcome.

Стилі APA, Harvard, Vancouver, ISO та ін.

37

SINGH, JASVINDER A., WILL J. TAYLOR, LEE S. SIMON, PUJA P. KHANNA, LISA K. STAMP, FIONA M. McQUEEN, TUHINA NEOGI, et al. "Patient-reported Outcomes in Chronic Gout: A Report from OMERACT 10." Journal of Rheumatology 38, no. 7 (July 2011): 1452–57. http://dx.doi.org/10.3899/jrheum.110271.

Повний текст джерела

Анотація:

Objective.To summarize the endorsement of measures of patient-reported outcome (PRO) domains in chronic gout at the 2010 Outcome Measures in Rheumatology Meeting (OMERACT 10).Methods.During the OMERACT 10 gout workshop, validation data were presented for key PRO domains including pain [pain by visual analog scale (VAS)], patient global (patient global VAS), activity limitation [Health Assessment Questionnaire-Disability Index (HAQ-DI)], and a disease-specific measure, the Gout Assessment Questionnaire version 2.0 (GAQ v2.0). Data were presented on all 3 aspects of the OMERACT filters of truth, discrimination, and feasibility. One PRO, health-related quality of life measurement with the Medical Outcomes Study Short-form 36 (SF-36), was previously endorsed at OMERACT 9.Results.One measure for each of the 3 PRO of pain, patient global, and activity limitation was endorsed by > 70% of the OMERACT delegates to have appropriate validation data. Specifically, pain measurement by VAS was endorsed by 85%, patient global assessment by VAS by 73%, and activity limitation by HAQ-DI by 71%. GAQ v2.0 received 30% vote and was not endorsed due to several concerns including low internal consistency and lack of familiarity with the measure. More validation studies are needed for this measure.Conclusion.With the endorsement of one measure each for pain, patient global, SF-36, and activity limitation, all 4 PRO for chronic gout have been endorsed. Future validation studies are needed for the disease-specific measure, GAQ v2.0. Validation for PRO for acute gout will be the focus of the next validation exercise for the OMERACT gout group.

Стилі APA, Harvard, Vancouver, ISO та ін.

38

Clark, Michael E., Ronald J. Gironda, and Robert W. Young. "Development and validation of the Pain Outcomes Questionnaire-VA." Journal of Rehabilitation Research and Development 40, no. 5 (2003): 381. http://dx.doi.org/10.1682/jrrd.2003.09.0381.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

39

Gary, Sarah T., Antonio V. Otero, Kenneth G. Faulkner, and Nadeeka R. Dias. "Validation and equivalency of electronic clinical outcomes assessment systems." International Journal of Clinical Trials 7, no. 4 (October 20, 2020): 271. http://dx.doi.org/10.18203/2349-3259.ijct20204485.

Повний текст джерела

Анотація:

<p>The US food and drug administration (FDA) has long called for clinical outcomes assessments (COA), such as patient-reported outcomes (PRO), to be ‘fit-for-purpose’ meaning the COA has been validated to support the context of use. The FDA’s recent patient-focused drug development guidance series has renewed the importance of ensuring that COA is ‘fit-for-purpose’ and valid. In addition, the FDA has recommended that COA be collected electronically and that the electronic (eCOA) system and devices also be validated. Advancing technology requires eCOA systems and devices to evolve; eCOA devices may change over time. As bring your own device (BYOD) models gain popularity and acceptance, devices may also be mixed within trials. Changes in eCOA devices or mixing devices may require equivalence testing to prove validity across platforms. The aim of this article is to provide an overview of the different types of validation at both the assessment level and the eCOA system (device) level to help clinical trial sponsors determine the appropriate level of validation or equivalence testing required for COA used in their clinical trials. </p>

Стилі APA, Harvard, Vancouver, ISO та ін.

40

Fleming, Michael, Jean-Christophe Sublet, Mark R. Gilbert, Arjan Koning, and Dimitri Rochman. "TALYS/TENDL verification and validation processes: Outcomes and recommendations." EPJ Web of Conferences 146 (2017): 02033. http://dx.doi.org/10.1051/epjconf/201714602033.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

41

Young, Matthew M., and Michael J. A. Wohl. "The Gambling Craving Scale: Psychometric validation and behavioral outcomes." Psychology of Addictive Behaviors 23, no. 3 (September 2009): 512–22. http://dx.doi.org/10.1037/a0015043.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

42

de Fátima Lucena, Amália, Ilesca Holsbach, Lisiane Pruinelli, Adriana Serdotte Freitas Cardoso, and Bruna Schroeder Mello. "Brazilian Validation of the Nursing Outcomes for Acute Pain." International Journal of Nursing Knowledge 24, no. 1 (October 16, 2012): 54–58. http://dx.doi.org/10.1111/j.2047-3095.2012.01230.x.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

43

Lee, Eun Joo. "Validation of Nursing Care Sensitive Outcomes related to Knowledge." Journal of Korean Academy of Nursing 33, no. 5 (2003): 625. http://dx.doi.org/10.4040/jkan.2003.33.5.625.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

44

Gazali, Novri, and Romi Cendra. "The Validation of Badminton Textbook: Improving Students' Learning Outcomes." Universal Journal of Educational Research 8, no. 7 (July 2020): 3224–29. http://dx.doi.org/10.13189/ujer.2020.080751.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

45

Mortenson, W. Ben, Louise Demers, Paula W. Rushton, Claudine Auger, Francois Routhier, and William C. Miller. "Exploratory Validation of a Multidimensional Power Wheelchair Outcomes Toolkit." Archives of Physical Medicine and Rehabilitation 96, no. 12 (December 2015): 2184–93. http://dx.doi.org/10.1016/j.apmr.2015.08.430.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

46

Chang, Wenbing, Yinglai Liu, Yiyong Xiao, Xinglong Yuan, Xingxing Xu, Siyue Zhang, and Shenghan Zhou. "A Machine-Learning-Based Prediction Method for Hypertension Outcomes Based on Medical Data." Diagnostics 9, no. 4 (November 7, 2019): 178. http://dx.doi.org/10.3390/diagnostics9040178.

Повний текст джерела

Анотація:

The outcomes of hypertension refer to the death or serious complications (such as myocardial infarction or stroke) that may occur in patients with hypertension. The outcomes of hypertension are very concerning for patients and doctors, and are ideally avoided. However, there is no satisfactory method for predicting the outcomes of hypertension. Therefore, this paper proposes a prediction method for outcomes based on physical examination indicators of hypertension patients. In this work, we divide the patients’ outcome prediction into two steps. The first step is to extract the key features from the patients’ many physical examination indicators. The second step is to use the key features extracted from the first step to predict the patients’ outcomes. To this end, we propose a model combining recursive feature elimination with a cross-validation method and classification algorithm. In the first step, we use the recursive feature elimination algorithm to rank the importance of all features, and then extract the optimal features subset using cross-validation. In the second step, we use four classification algorithms (support vector machine (SVM), C4.5 decision tree, random forest (RF), and extreme gradient boosting (XGBoost)) to accurately predict patient outcomes by using their optimal features subset. The selected model prediction performance evaluation metrics are accuracy, F1 measure, and area under receiver operating characteristic curve. The 10-fold cross-validation shows that C4.5, RF, and XGBoost can achieve very good prediction results with a small number of features, and the classifier after recursive feature elimination with cross-validation feature selection has better prediction performance. Among the four classifiers, XGBoost has the best prediction performance, and its accuracy, F1, and area under receiver operating characteristic curve (AUC) values are 94.36%, 0.875, and 0.927, respectively, using the optimal features subset. This article’s prediction of hypertension outcomes contributes to the in-depth study of hypertension complications and has strong practical significance.

Стилі APA, Harvard, Vancouver, ISO та ін.

47

Carragee, Eugene, Ivan Cheng, and Mark Wang. "3. Validation of a “Minimum Acceptable Outcomes” Model for Outcomes Assessment in Spinal Surgery." Spine Journal 7, no. 5 (September 2007): 2S. http://dx.doi.org/10.1016/j.spinee.2007.07.007.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

48

Kalluri, Meena, Fabrizio Luppi, Ada Vancheri, Carlo Vancheri, Elisabetta Balestro, Francesco Varone, Nesrin Mogulkoc, et al. "Patient-reported outcomes and patient-reported outcome measures in interstitial lung disease: where to go from here?" European Respiratory Review 30, no. 160 (May 25, 2021): 210026. http://dx.doi.org/10.1183/16000617.0026-2021.

Повний текст джерела

Анотація:

Patient-reported outcome measures (PROMs), tools to assess patient self-report of health status, are now increasingly used in research, care and policymaking. While there are two well-developed disease-specific PROMs for interstitial lung diseases (ILD) and idiopathic pulmonary fibrosis (IPF), many unmet and urgent needs remain. In December 2019, 64 international ILD experts convened in Erice, Italy to deliberate on many topics, including PROMs in ILD. This review summarises the history of PROMs in ILD, shortcomings of the existing tools, challenges of development, validation and implementation of their use in clinical trials, and the discussion held during the meeting. Development of disease-specific PROMs for ILD including IPF with robust methodology and validation in concordance with guidance from regulatory authorities have increased user confidence in PROMs. Minimal clinically important difference for bidirectional changes may need to be developed. Cross-cultural validation and linguistic adaptations are necessary in addition to robust psychometric properties for effective PROM use in multinational clinical trials. PROM burden of use should be reduced through appropriate use of digital technologies and computerised adaptive testing. Active patient engagement in all stages from development, testing, choosing and implementation of PROMs can help improve probability of success and further growth.

Стилі APA, Harvard, Vancouver, ISO та ін.

49

Yassien, Sahar, and Mona Hamdi. "Measuring Nursing Sensitive Outcomes in Patient with Acute Myocardial Infarction: Tool Development and Validation." Evidence-Based Nursing Research 1, no. 1 (April 11, 2019): 12. http://dx.doi.org/10.47104/ebnrojs3.v1i1.32.

Повний текст джерела

Анотація:

Context: The outcomes movement is a young science, improving care by determining the outcomes of nursing interventions will give scientific validity to strategies that are used by nursing in a variety of venues. Cardiovascular nurses contribute significantly to health outcomes and frequently assume responsibility for the clinical and organizational processes to ensure positive outcomes for patients and families Aims: The aims of this study were to identify nursing-sensitive outcomes in patients with acute myocardial infarction, to develop a tool to measure nursing-sensitive outcomes of caring patients with myocardial infarction, and to evaluate the content, face validity, reliability and nursing sensitivity of 46 nursing sensitive-outcomes concerning bio-psycho-socio- educational aspects of care for patients with myocardial infarction from the Nursing Outcomes Classification (NOC). Methods: A survey research design was used in this study to assess the content and face validity of the designed instrument and inter-rater reliability was utilized to assure its reliability. Thirty patients with acute myocardial infarction subjected to measuring their nursing-sensitive outcomes during their stay in the CCUs or intermediate units. Fifty-nine experts were invited to participate in this study. Nursing-Sensitive Outcomes Measuring Scale was developed and subjected to testing reliability, validity, and sensitivity Results: Most of the studied outcomes showed a high degree of consistency as indicated by ICC that was above 0.900. 100% of the experts rated 14 out of 46 outcomes as very important; the remaining outcomes were assessed by more than 75% of the experts as important. Also, 18 out of 46 outcomes were rated by the 100% experts as very sensitive to the contribution of nursing intervention; no one outcome was rated as not important or not sensitive for nursing contribution. Conclusions: The study provided evidence of outcomes content validity, reliability, and nursing sensitivity of the studied outcomes. The study recommended the testing of NOC outcomes in various clinical settings with appropriate training for nurses, and the inclusion of NOC into nursing curricula to utilized in clinical education as a continuum for nursing diagno- ses classification.

Стилі APA, Harvard, Vancouver, ISO та ін.

50

Bashofi, Ferdinan, and Suheri Widianto. "PENGEMBANGAN MEDIA DIGITAL SITUS CANDI JAGO DALAM MENINGKATKAN HASIL BELAJAR MAHASISWA SEJARAH IKIP BUDI UTOMO MALANG." Paradigma: Jurnal Filsafat, Sains, Teknologi, dan Sosial Budaya 24, no. 1 (January 10, 2018): 57–62. http://dx.doi.org/10.33503/paradigma.v24i1.343.

Повний текст джерела

Анотація:

The purpose of this research is to design the learning media of Indonesian cultural history, and to describe the effect of media usage on student learning outcomes. This research is a development research using Sugiyono model, while tehadap learning result using pseudo experiment to know effectiveness to result learn. The findings in the field show there are 4 relics of the temple building from the Hindu-Buddhist era and which is used as a model is Jago temple. The result of validity test of learning media is expressed well by validator with obtained validation result: 75,5% from media expert which mean included in criterion good enough, while from material expert equal to 80% good category. Result of data of questionnaires validation of practitioner 1 validation toward learning media obtained percentage 85%. Learning media developed after tested try to get good response from students with percentage of 81% with good category. Learning media developed effectively because after tested, and obtained the results: (1) the average learning outcomes in the form of absorption of material comprehension, the number of students who complete learning as much as 28 of 29 students with students’ learning completeness classically is 96.5% average value 84.48, (2) students’ experimental class learning outcomes are better than control class, (3) there is statistically significant difference or significant use of digital learning media of jago temple site to increase student learning outcomes.

Стилі APA, Harvard, Vancouver, ISO та ін.

Статті в журналах з теми "Outcomes validation"

Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями